Assistant Professor, Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
I serve as a Master Clinician within my department and my focus is on patient care and expertise in treating patients with sarcoma. I am not the lead on any active research projects within my division. I do not have any ongoing research projects at this time. I am a collaborator on all open protocols within my department. When my schedule allows, I do look forward to investing time in a project that will impact the care of sarcomas. I have training in Clinical Safety and Effectiveness and hope to one day incorporate this into a meaningful project for patient care.
|2006||University of Texas Health Science Center at San Antonio, San Antonio, TX, USA, MD, Internal Medicine|
|2000||Rice University, Houston, TX, USA, BS, Biology|
|2010-2013||Clinical Fellowship, University of Texas M.D. Anderson Cancer Center, Houston, TX|
|2009-2010||Chief Resident, Internal Medicine, University of Texas Medical School, Houston, TX|
|2006-2009||Clinical Residency, Internal Medicine, University of Texas Medical School, Houston, TX|
|2013||Board Eligible of Medical Oncology|
|2013||Board Eligible of Hematology|
|2010||American Board of Internal Medicine|
Clinical Specialist, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - Present
Instructor, Department of Gynecologic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2010
|2010||Herbert L. Fred Award|
|2007||Outstanding Intern of the Year Award, Department of Internal Medicine, UT Medical School at Houston|
- Bishop AJ, Zarzour MA, Ratan R, Torres KE, Feig BW, Wang WL, Lazar AJ, Moon BS, Roland CL, Guadagnolo BA. Long-term outcomes for patients with desmoid fibromatosis treated with radiation therapy: a 10-year update and re-evaluation of the role of radiation therapy for younger patients. Int J Radiat Oncol Biol Phys 103(5):1167-1174, 2019. e-Pub 2018. PMID: 30552963.
- Wagner MJ, Gopalakrishnan V, Ravi V, Livingston JA, Conley AP, Araujo D, Somaiah N, Zarzour MA, Ratan R, Wang WL, Patel SR, Lazar A, Ludwig JA, Benjamin RS. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults. Oncologist 22(10):1271-1277, 2017. e-Pub 2017. PMID: 28710342.
- Schvartsman G, Wagner MJ, Amini B, Zobniw CM, Trinh VA, Barbo AG, Lin HY, Wang WL, Conley AP, Ravi V, Araujo DM, Zarzour MA, Benjamin RS, Patel S, Somaiah N. Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients. Sci Rep 7(1):9519, 2017. e-Pub 2017. PMID: 28842575.
- Subbiah V, Holmes O, Gowen K, Spritz D, Amini B, Wang WL, Schrock AB, Meric-Bernstam F, Zinner R, Piha-Paul S, Zarzour M, Elvin JA, Erlich RL, Stockman DL, Vergilio JA, Suh JH, Stephens PJ, Miller V, Ross JS, Ali SM. Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion. Oncology 91(6):348-353, 2016. e-Pub 2016. PMID: 27764830.